Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychoticsBRADFORD, Andrea M; SAVAGE, Kevin M; JONES, Declan N. C et al.Psychopharmacologia. 2010, Vol 212, Num 2, pp 155-170, issn 0033-3158, 16 p.Article

(±) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychoticsCILIA, Jackie; HATCHER, Paula; REAVILL, Charlie et al.Journal of psychopharmacology (Oxford). 2007, Vol 21, Num 3, pp 302-311, issn 0269-8811, 10 p.Article

Urotensin-II, a neuropeptide ligand for GPR14, induces c-fos in the rat brainGARTLON, Jane E; ASHMEADE, Tracey; DUXON, Mark et al.European journal of pharmacology. 2004, Vol 493, Num 1-3, pp 95-98, issn 0014-2999, 4 p.Article

Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the ratKIRK, Shona L; NEILL, Joanna C; JONES, Declan N. C et al.European journal of pharmacology. 2004, Vol 505, Num 1-3, pp 253-254, issn 0014-2999, 2 p.Article

In vitro and in vivo comparison of two non-peptide tachykinin NK₃ receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristicsDAWSON, Lee A; LANGMEAD, Christopher J; HILL, Mark D et al.European journal of pharmacology. 2010, Vol 627, Num 1-3, pp 106-114, issn 0014-2999, 9 p.Article

Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague-Dawley rats : A locomotor activity and gene induction studyKALINICHEV, Mikhail; ROBBINS, Melanie J; HARTFIELD, Elizabeth M et al.Progress in neuro-psychopharmacology & biological psychiatry. 2008, Vol 32, Num 2, pp 414-422, issn 0278-5846, 9 p.Article

Characterization of the binding of [¹²⁵I]-human prolactin releasing peptide (PrRP) to GPR10, a novel G protein coupled receptorLANGMEAD, Christopher J; SZEKERES, Philip G; CHAMBERS, Jonathan K et al.British journal of pharmacology. 2000, Vol 131, Num 4, pp 683-688, issn 0007-1188Article

The relationship between sodium channel inhibition and anticonvulsant activity in a model of generalised seizure in the ratLARGE, Charles H; KALINICHEV, Mikhail; ALVARO, Giuseppe et al.Epilepsy research. 2009, Vol 85, Num 1, pp 96-106, issn 0920-1211, 11 p.Article

Studies towards the identification of a new generation of atypical antipsychotic agentsGARZYA, Vincenzo; FORBES, Ian T; MEESON, Malcom et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 2, pp 400-405, issn 0960-894X, 6 p.Article

Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX₁) receptors, with downstream 5-HT_2C receptor involvementDUXON, Mark S; STRETTON, Jennifer; WAI CHAN et al.Psychopharmacologia. 2001, Vol 153, Num 2, pp 203-209, issn 0033-3158Article

Potentiation of the anticonvulsant efficacy of sodium channel inhibitors by an NKI -receptor antagonist in the ratKALINICHEV, Mikhail; BRADFORD, Andrea; READ, Kevin D et al.Epilepsia (Copenhagen). 2010, Vol 51, Num 8, pp 1543-1551, issn 0013-9580, 9 p.Article

Preclinical investigations into the antipsychotic potential of the novel histamine H₃ receptor antagonist GSK207040SOUTHAM, Eric; CILIA, Jackie; DAWSON, Lee A et al.Psychopharmacologia. 2009, Vol 201, Num 4, pp 483-494, issn 0033-3158, 12 p.Article

Effects of the atypical antipsychotics olanzapine and risperidone on plasma prolactin levels in male rats : a comparison with clinical dataROURKE, Claire; STARR, Kathryn R; REAVILL, Charlie et al.Psychopharmacologia. 2006, Vol 184, Num 1, pp 107-114, issn 0033-3158, 8 p.Article

Orexin expression and function : Glucocorticoid manipulation, stress, and feeding studiesFORD, Gemma K; AL-BARAZANJI, Kamal A; WILSON, Shelagh et al.Endocrinology (Philadelphia). 2005, Vol 146, Num 9, pp 3724-3731, issn 0013-7227, 8 p.Article

5-HT₆ receptor antagonists improve performance in an attentional set shifting task in ratsHATCHER, Paula D; BROWN, Verity J; TAIT, David S et al.Psychopharmacologia. 2005, Vol 181, Num 2, pp 253-259, issn 0033-3158, 7 p.Article

In Vitro and In Vivo Characterization of the Non-peptide N K₃ Receptor Antagonist SB-223412 (Talnetant) : Potential Therapeutic Utility in the Treatment of SchizophreniaDAWSON, Lee A; CATO, Katherine J; SOUTHAM, Eric et al.Neuropsychopharmacology (New York, NY). 2008, Vol 33, Num 7, pp 1642-1652, issn 0893-133X, 11 p.Article

Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophreniaROBBINS, Melanie J; STARR, Kathryn R; ROCHEUILLE, Magalie et al.Brain research. 2007, Vol 1152, pp 215-227, issn 0006-8993, 13 p.Article

Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female ratsKALINICHEV, Mikhail; ROURKE, Claire; DANIELS, Alex J et al.Psychopharmacologia. 2005, Vol 182, Num 2, pp 220-231, issn 0033-3158, 12 p.Article

Central effects of urotensin-II following ICV administration in ratsGARTLON, Jane; PARKER, Frederick; HUNTER, Jackie A et al.Psychopharmacologia. 2001, Vol 155, Num 4, pp 426-433, issn 0033-3158Article

Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolationHEIDBREDER, Christian A; FOXTON, Richard; CILIA, Jackie et al.Psychopharmacologia. 2001, Vol 156, Num 2-3, pp 338-351, issn 0033-3158Article

Effect of the selective dopamine D₃ receptor antagonist SB-277011-A on regional c-Fos-like expression in rat forebrainSOUTHAM, Eric; LLOYD, Andrew; JENNINGS, Carol A et al.Brain research. 2007, Vol 1149, pp 50-57, issn 0006-8993, 8 p.Article

Aripiprazole and its human metabolite are partial agonists at the human dopamine D₂ receptor, but the rodent metabolite displays antagonist propertiesWOOD, Martyn D; SCOTT, Claire; FORBES, Ian T et al.European journal of pharmacology. 2006, Vol 546, Num 1-3, pp 88-94, issn 0014-2999, 7 p.Article

Reversal of isolation-rearing-induced PPI deficits by an α7 nicotinic receptor agonistCILIA, Jackie; CLUDERAY, Jane E; ROBBINS, Melanie J et al.Psychopharmacologia. 2005, Vol 182, Num 2, pp 214-219, issn 0033-3158, 6 p.Article

Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in ratsGARTLON, Jane; SZEKERES, Philip; DUXON, Mark et al.Psychopharmacologia. 2004, Vol 177, Num 1-2, pp 1-14, issn 0033-3158, 14 p.Article

Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivityJONES, Declan N. C; GARTLON, Jane; PORTER, Rod A et al.Psychopharmacologia. 2001, Vol 153, Num 2, pp 210-218, issn 0033-3158Article